Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02510694

Ligand	Ligand name	Chain	PDB	Tanimoto
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.79
CLR	CHOLESTEROL	A,B	2ZXE	0.73
CLR	CHOLESTEROL	A	1N83	0.73
CLR	CHOLESTEROL	A	2RH1	0.73
CLR	CHOLESTEROL	A	1LRI	0.73
CLR	CHOLESTEROL	A	1ZHY	0.73
CLR	CHOLESTEROL	A	3D4S	0.73
LAN	LANOSTEROL	A	1W6K	0.71
TES	TESTOSTERONE	A	1JTV	0.72
TES	TESTOSTERONE	A	2Q7L	0.72
TES	TESTOSTERONE	A	2Q7I	0.72
TES	TESTOSTERONE	A,B	1J96	0.72
TES	TESTOSTERONE	A	2Q7K	0.72
TES	TESTOSTERONE	A,B	1Q13	0.72
TES	TESTOSTERONE	H	1I9J	0.72
TES	TESTOSTERONE	A,B	1AFS	0.72
TES	TESTOSTERONE	H	1VPO	0.72
TES	TESTOSTERONE	A	2Q7J	0.72
TES	TESTOSTERONE	A,B	3BUR	0.72
TES	TESTOSTERONE	A	2AM9	0.72
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.71
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A	2GJ5	0.77
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A,B	3C6G	0.77
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.74
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.79
XE4	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	A	2HBH	0.74
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.79
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.79
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.78
FUG	FUMAGILLIN	A,B	3FMQ	0.71
FUG	FUMAGILLIN	A	1BOA	0.71
TX5	(1R,3R)-5-((Z)-2-((1R,7AS)-HEXAHYDRO-1-((S)-6-HYDROXY-6-METHYLHEPT-4-YN-2-YL)-7A-METHYL-1H-INDEN-4(7AH)-YLIDENE)ETHYLIDENE)CYCLOHEXANE-1,3-DIOL	A	1TXI	0.74
VD4	(1R,3R,7E,17Z)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4J	0.77
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.76
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.72
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.75
NEX		A,B,C,D,E,F,G,H,I,J	1RWT	0.7
NEX		A,B,C	2BHW	0.7
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.79
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.8
DEX	DEXAMETHASONE	A,D	1M2Z	0.71
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.71
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.77
VD1	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RKG	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.72
PID	PERIDININ	A	2C9E	0.7
PID	PERIDININ	M,N,O	1PPR	0.7
MC9	CALCIPOTRIOL	A	1S19	0.74
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.7
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.76
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.77
EB1	SEOCALCITOL	A	1S0Z	0.77
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.72
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.81
LUT	(3R,3'R,6S)-4,5-DIDEHYDRO-5,6-DIHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C,D,E,F,G,H,I,J	1RWT	0.73
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.75
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.78
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.79
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.75
ERG	ERGOSTEROL	A	1BXM	0.77
ERG	ERGOSTEROL	A	1ZHZ	0.77
ERG	ERGOSTEROL	A,B	2AIB	0.77
AS4	ALDOSTERONE	A	2AA2	0.71
AS4	ALDOSTERONE	A	2Q1H	0.71
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.73
C0R	CORTICOSTERONE	A	2A3I	0.7
C0R	CORTICOSTERONE	A,B	1Y5R	0.7
3ON	(3R)-3-HYDROXY-8'-APOCAROTENOL	A,B,C,D	2BIW	0.71
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.72
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.82
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.82
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.74
VD5	(1R,3R,7E,17E)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4R	0.77
AXT	ASTAXANTHIN	A,B	1GKA	0.73
D2V	(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol	A,B	3CZH	0.78